# Role of Endothelial Progenitor Cells Dysregulation and Inflammation in the Pathophysiology of Cardiovascular Complications of Type 2 Diabetes

> **NCT07556497** · — · RECRUITING · sponsor: **Weill Cornell Medical College in Qatar** · enrollment: 90 (estimated)

## Conditions studied

- Diabete Type 2
- Cardio Vascular Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07556497
- **Lead sponsor:** Weill Cornell Medical College in Qatar
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-11-17
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-04-29

## Collaborators

- Hamad Medical Corporation

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07556497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07556497, "Role of Endothelial Progenitor Cells Dysregulation and Inflammation in the Pathophysiology of Cardiovascular Complications of Type 2 Diabetes". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07556497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*